Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mycobacterial ATP synthase c-ring, primarily composed of the c-subunit (encoded by the atpE gene), is a critical component of the F0 sector of the F1F0-ATP synthase enzyme complex [9, 10]. This complex is responsible for synthesizing adenosine triphosphate (ATP), the primary energy currency of the cell, by utilizing the proton motive force across the bacterial membrane [1, 6]. The c-ring acts as a rotary motor that translocates protons; as protons move through the interface between the a-subunit and the c-ring, the ring rotates, driving the central stalk to catalyze ATP production in the F1 domain [10, 14, 20]. In Mycobacterium tuberculosis, this process is essential for survival in both replicating and non-replicating states [1, 6]. This target is clinically validated by the diarylquinoline drug bedaquiline, which binds specifically to the c-subunit to stall the rotation of the c-ring, leading to lethal ATP depletion [3, 12, 14]. While highly effective against multidrug-resistant tuberculosis, drugs targeting this molecule must be monitored for safety concerns such as QTc prolongation and the development of resistance through atpE mutations [8, 12, 14]. The high selectivity of bedaquiline for mycobacterial over human mitochondrial ATP synthase is a key factor in its therapeutic index [1, 12].
Inhibition of the F1F0-ATP synthase by binding to the c-subunit of the F0 rotor, which stalls the rotation of the c-ring and prevents the mechanical coupling of proton translocation to ATP synthesis, leading to cellular ATP depletion and bactericidal activity.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP synthase subunit c (Mycobacterial) (atpE).